These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2140018)

  • 1. Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects.
    Smits GJ; McGraw DE; Trapani AJ
    Am J Physiol; 1990 May; 258(5 Pt 2):F1417-24. PubMed ID: 2140018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide.
    Trapani AJ; Smits GJ; McGraw DE; Spear KL; Koepke JP; Olins GM; Blaine EH
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):419-24. PubMed ID: 2476621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endogenous atrial natriuretic peptide in regulating sodium excretion in spontaneously hypertensive rats. Effects of neutral endopeptidase inhibition.
    Hirata Y; Matsuoka H; Hayakawa H; Sugimoto T; Suzuki E; Sugimoto T; Kangawa K; Matsuo H
    Hypertension; 1991 Jun; 17(6 Pt 2):1025-32. PubMed ID: 1828456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
    Wegner M; Ganten D; Stasch JP
    Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
    Trapani AJ; Beil ME; Coté DT; de Lombaert S; Erion MD; Gerlock TE; Ghai RD; Hopkins MF; Peppard JV; Webb RL
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):358-64. PubMed ID: 7515977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
    Wegner M; Stasch JP; Hirth-Dietrich C; Dressel J; Voges KP; Kazda S
    Clin Exp Hypertens; 1995 Aug; 17(6):861-76. PubMed ID: 7581258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats.
    Koepke JP; Tyler LD; Trapani AJ; Bovy PR; Spear KL; Olins GM; Blaine EH
    J Pharmacol Exp Ther; 1989 Apr; 249(1):172-6. PubMed ID: 2565386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal response of anesthetized rats to low-dose infusion of atrial natriuretic peptide.
    Soejima H; Grekin RJ; Briggs JP; Schnermann J
    Am J Physiol; 1988 Sep; 255(3 Pt 2):R449-55. PubMed ID: 2970807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the renal response to endopeptidase inhibition and atrial natriuretic peptide infusion in normal dogs.
    Levy M; Cernacek P
    Can J Physiol Pharmacol; 1992 Dec; 70(12):1563-70. PubMed ID: 1301233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
    J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enkephalinase inhibition increases plasma atrial natriuretic peptide levels, glomerular filtration rate, and urinary sodium excretion in rats with reduced renal mass.
    Lafferty HM; Gunning M; Silva P; Zimmerman MB; Brenner BM; Anderson S
    Circ Res; 1989 Sep; 65(3):640-6. PubMed ID: 2548762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natriuretic mechanisms of neutral endopeptidase inhibitor in rats.
    Shimamoto K; Ura N; Iimura O
    Braz J Med Biol Res; 1994 Aug; 27(8):1965-73. PubMed ID: 7749388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
    Cruden NL; Fox KA; Ludlam CA; Johnston NR; Newby DE
    Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
    Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between bradykinin and ANP in rat kidney in vitro: inhibition of natriuresis and modulation of medullary cyclic GMP.
    Boric MP; Bravo JA; Corbalan M; Vergara C; Roblero JS
    Biol Res; 1998; 31(3):281-9. PubMed ID: 9830516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
    Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
    J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.